This clinical trial is focused on studying the effects of stopping or gradually reducing the use of glucocorticoids, a type of steroid medication, in patients with inflammatory or autoimmune disorders. These disorders occur when the body’s immune system mistakenly attacks its own tissues, causing inflammation and other symptoms. The medication being studied is Prednisone, which is commonly used to reduce inflammation and suppress the immune system. The trial will compare two approaches: stopping the medication immediately or gradually reducing the dose over four weeks.
The purpose of the study is to determine if stopping glucocorticoid treatment quickly is as safe and effective as slowly reducing the dose. Participants will be randomly assigned to one of the two groups. Some participants will receive a placebo, which looks like the medication but does not contain the active ingredient. The study will last for a period of up to 28 days, during which participants will be monitored for any health changes, including the need for additional treatment or any serious health events.
Throughout the study, participants’ overall health and any symptoms they experience will be closely observed. This includes monitoring for signs of adrenal insufficiency, a condition where the body does not produce enough of certain hormones after stopping steroid treatment. The study aims to provide valuable information on the best way to discontinue glucocorticoid therapy in patients with inflammatory conditions, ensuring their safety and well-being.



Germany